263 research outputs found
Design and Approach of a Storm Runoff Investigation at Selected South Carolina Department of Transportation Maintenance Yards
2010 S.C. Water Resources Conference - Science and Policy Challenges for a Sustainable Futur
An update on peptide-based therapies for type 2 diabetes and obesity
Long-acting analogues of the naturally occurring incretin, glucagon-like peptide-1 (GLP-1) and those modified to interact also with receptors for glucose-dependent insulinotropic polypeptide (GIP) have shown high glucose-lowering and weight-lowering efficacy when administered by once-weekly subcutaneous injection. These analogues herald an exciting new era in peptide-based therapy for type 2 diabetes (T2D) and obesity. Of note is the GLP-1R agonist semaglutide, available in oral and injectable formulations and in clinical trials combined with the long-acting amylin analogue, cagrilintide. Particularly high efficacy in both glucose- and weight lowering capacities has also been observed with the GLP-1R/GIP-R unimolecular dual agonist, tirzepatide. In addition, a number of long-acting unimolecular GLP-1R/GCGR dual agonist peptides and GLP-1R/GCGR/GIPR triagonist peptides have entered clinical trials. Other pharmacological approaches to chronic weight management include the human monoclonal antibody, bimagrumab which blocks activin type II receptors and is associated with growth of skeletal muscle, an antibody blocking activation of GIPR to which are conjugated GLP-1R peptide agonists (AMG-133), and the melanocortin-4 receptor agonist, setmelanotide for use in certain inherited obesity conditions. The high global demand for the GLP-1R agonists liraglutide and semaglutide as anti-obesity agents has led to shortage so that their use in T2D therapy is currently being prioritized. [Abstract copyright: Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients
Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients.Background. Staphylococcus aureusbacteremia is frequently associated with metastatic complications and infective endocarditis (IE). The Duke criteria for the diagnosis of IE utilize echocardiographic techniques and are more sensitive than previous criteria. The documentation of IE in patients undergoing hemodialysis (HD) has become increasingly important in order to avoid the overuse of empiric vancomycin and the emergence of antibiotic resistance.MethodsPatients who developed S. aureus bacteremia while undergoing HD at a tertiary medical center or one of four affiliated outpatient HD units were identified. Clinical outcome (death, metastatic complications, IE, and microbiologic recurrence) was assessed during hospitalization and at three months after discharge. Transthoracic and transesophageal echocardiograms were performed and the Duke criteria were used to diagnose IE. Pulse field gel electrophoresis was performed to confirm genetic similarity of recurrent isolates.ResultsFour hundred and forty-five patients underwent hemodialysis for 5431.8 patient-months. Sixty-two developed 65 episodes of S. aureus bacteremia (1.2 episodes/100 patient-months). Complications occurred in 27 (44%) patients. Bacteremia recurred in patients who dialyzed through polytetrafluorethylene grafts (44.4% vs. 7.1%, P = 0.0.01), and there was a trend to increased recurrence in patients who received only vancomycin (19.5% vs. 7.1%, P = 0.4). IE was diagnosed in 8 patients (12%), six of whom had normal transthoracic echocardiograms.ConclusionsSensitive echocardiographic techniques and the Duke criteria for the diagnosis of IE should be used to determine the proper duration of antibiotic therapy in hemodialysis patients with S. aureus bacteremia. This diagnostic approach, coupled with early removal of hardware, may assist in improving outcomes
Comprehensive Investigation of the Caveolin 2 Gene: Resequencing and Association for Kidney Transplant Outcomes
Caveolae are plasma membrane structures formed from a complex of the proteins caveolin-1 and caveolin-2. Caveolae interact with pro-inflammatory cytokines and are dysregulated in fibrotic disease. Although caveolae are present infrequently in healthy kidneys, they are abundant during kidney injury. An association has been identified between a CAV1 gene variant and long term kidney transplant survival. Chronic, gradual decline in transplant function is a persistent problem in kidney transplantation. The aetiology of this is diverse but fibrosis within the transplanted organ is the common end point. This study is the first to investigate the association of CAV2 gene variants with kidney transplant outcomes. Genomic DNA from donors and recipients of 575 kidney transplants performed in Belfast was investigated for common variation in CAV2 using a tag SNP approach. The CAV2 SNP rs13221869 was nominally significant for kidney transplant failure. Validation was sought in an independent group of kidney transplant donors and recipients from Dublin, Ireland using a second genotyping technology. Due to the unexpected absence of rs13221869 from this cohort, the CAV2 gene was resequenced. One novel SNP and a novel insertion/deletion in CAV2 were identified; rs13221869 is located in a repetitive region and was not a true variant in resequenced populations. CAV2 is a plausible candidate gene for association with kidney transplant outcomes given its proximity to CAV1 and its role in attenuating fibrosis. This study does not support an association between CAV2 variation and kidney transplant survival. Further analysis of CAV2 should be undertaken with an awareness of the sequence complexities and genetic variants highlighted by this study
Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy. We aimed to establish patterns of disease recurrence and to identify factors associated with disease recurrence. Methods. We accessed the Irish renal transplant database to identify patients with biopsy-proven idiopathic membranous nephropathy in receipt of a renal transplant between 1982 and 2010. A detailed medical chart review was performed in all cases, and a senior renal histopathologist reviewed all histology specimens. Results. The outcomes of 32 patients, in receipt of 36 grafts, are reported. There was a male preponderance ( = 29). Significant graft dysfunction, directly attributable to recurrent disease, was evident in 31% of cases at 10 years. There was no significant association between time on dialysis, HLA mismatch, occurrence of rejection, and the development of recurrent membranous disease. One patient was retransplanted twice; all three grafts were lost to aggressive recurrent membranous disease. Conclusions. It remains difficult to identify those that will develop recurrent membranous nephropathy. Almost one third of patients in this cohort developed clinically significant recurrent disease at 10 years
Axions In String Theory
In the context of string theory, axions appear to provide the most plausible
solution of the strong CP problem. However, as has been known for a long time,
in many string-based models, the axion coupling parameter F_a is several orders
of magnitude higher than the standard cosmological bounds. We re-examine this
problem in a variety of models, showing that F_a is close to the GUT scale or
above in many models that have GUT-like phenomenology, as well as some that do
not. On the other hand, in some models with Standard Model gauge fields
supported on vanishing cycles, it is possible for F_a to be well below the GUT
scale.Comment: 62 pages, v2; references, acknowledgements and minor corrections
adde
The Evolution of Sunspot Magnetic Fields Associated with a Solar Flare
Solar flares occur due to the sudden release of energy stored in
active-region magnetic fields. To date, the pre-cursors to flaring are still
not fully understood, although there is evidence that flaring is related to
changes in the topology or complexity of an active region's magnetic field.
Here, the evolution of the magnetic field in active region NOAA 10953 was
examined using Hinode/SOT-SP data, over a period of 12 hours leading up to and
after a GOES B1.0 flare. A number of magnetic-field properties and low-order
aspects of magnetic-field topology were extracted from two flux regions that
exhibited increased Ca II H emission during the flare. Pre-flare increases in
vertical field strength, vertical current density, and inclination angle of ~
8degrees towards the vertical were observed in flux elements surrounding the
primary sunspot. The vertical field strength and current density subsequently
decreased in the post-flare state, with the inclination becoming more
horizontal by ~7degrees. This behaviour of the field vector may provide a
physical basis for future flare forecasting efforts.Comment: Accepted for Publication in Solar Physics. 16 pages, 4 figure
MicroRNA profiling of the bovine alveolar macrophage response to Mycobacterium bovis infection suggests pathogen survival is enhanced by microRNA regulation of endocytosis and lysosome trafficking
peer-reviewedMycobacterium bovis, the causative agent of bovine tuberculosis, a major problem for global agriculture, spreads via an airborne route and is taken up by alveolar macrophages (AM) in the lung. Here, we describe the first next-generation sequencing (RNA-seq) approach to temporally profile miRNA expression in primary bovine AMs post-infection with M. bovis. One, six, and forty miRNAs were identified as significantly differentially expressed at 2, 24 and 48 h post-infection, respectively. The differential expression of three miRNAs (bta-miR-142-5p, bta-miR-146a, and bta-miR-423-3p) was confirmed by RT-qPCR. Pathway analysis of the predicted mRNA targets of differentially expressed miRNAs suggests that these miRNAs preferentially target several pathways that are functionally relevant for mycobacterial pathogenesis, including endocytosis and lysosome trafficking, IL-1 signalling and the TGF-β pathway. Over-expression studies using a bovine macrophage cell-line (Bomac) reveal the targeting of two key genes in the innate immune response to M. bovis, IL-1 receptor-associated kinase 1 (IRAK1) and TGF-β receptor 2 (TGFBR2), by miR-146. Taken together, our study suggests that miRNAs play a key role in tuning the complex interplay between M. bovis survival strategies and the host immune response
Metastable Vacua in Flux Compactifications and Their Phenomenology
In the context of flux compactifications, metastable vacua with a small
positive cosmological constant are obtained by combining a sector where
supersymmetry is broken dynamically with the sector responsible for moduli
stabilization, which is known as the F-uplifting. We analyze this procedure in
a model-independent way and study phenomenological properties of the resulting
vacua.Comment: 21 pages, 19 figures; v2: matches version published in JHE
Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance
The frog skin host-defense peptide esculentin-2CHa (GFSSIFRGVA10KFASKGLGK
D20LAKLGVDLVA30CKISKQC) displays antimicrobial, antitumor, and immunomodulatory
properties. This study investigated the antidiabetic actions of the peptide and selected analogues.
Esculentin-2CHa stimulated insulin secretion from rat BRIN-BD11 clonal pancreatic
β-cells at concentrations greater than 0.3 nM without cytotoxicity by a mechanism involving
membrane depolarization and increase of intracellular Ca2+. Insulinotropic activity was
attenuated by activation of KATP channels, inhibition of voltage-dependent Ca2+ channels
and chelation of extracellular Ca2+. The [L21K], [L24K], [D20K, D27K] and [C31S,C37S]
analogues were more potent but less effective than esculentin-2CHa whereas the [L28K]
and [C31K] analogues were both more potent and produced a significantly (P < 0.001)
greater maximum response. Acute administration of [L28K]esculentin-2CHa (75 nmol/kg
body weight) to high fat fed mice with obesity and insulin resistance enhanced glucose tolerance
and insulin secretion. Twice-daily administration of this dose of [L28K]esculentin-
2CHa for 28 days had no significant effect on body weight, food intake, indirect calorimetry
or body composition. However, mice exhibited decreased non-fasting plasma glucose
(P < 0.05), increased non-fasting plasma insulin (P < 0.05) as well as improved glucose tolerance
and insulin secretion (P < 0.01) following both oral and intraperitoneal glucose
loads. Impaired responses of isolated islets from high fat fed mice to established insulin
secretagogues were restored by [L28K]esculentin-2CHa treatment. Peptide treatment was
accompanied by significantly lower plasma and pancreatic glucagon levels and normalization
of α-cell mass. Circulating triglyceride concentrations were decreased but plasma cholesterol
and LDL concentrations were not significantly affected. The data encourage further
investigation of the potential of esculentin-2CHa related peptides for treatment of patients
with type 2 diabetes
- …